» Articles » PMID: 19620304

Nonredundant Roles for B Cell-derived IL-10 in Immune Counter-regulation

Abstract

IL-10 plays a central role in restraining the vigor of inflammatory responses, but the critical cellular sources of this counter-regulatory cytokine remain speculative in many disease models. Using a novel IL-10 transcriptional reporter mouse, we found an unexpected predominance of B cells (including plasma cells) among IL-10-expressing cells in peripheral lymphoid tissues at baseline and during diverse models of in vivo immunological challenge. Use of a novel B cell-specific IL-10 knockout mouse revealed that B cell-derived IL-10 nonredundantly decreases virus-specific CD8(+) T cell responses and plasma cell expansion during murine cytomegalovirus infection and modestly restrains immune activation after challenge with foreign Abs to IgD. In contrast, no role for B cell-derived IL-10 was evident during endotoxemia; however, although B cells dominated lymphoid tissue IL-10 production in this model, myeloid cells were dominant in blood and liver. These data suggest that B cells are an underappreciated source of counter-regulatory IL-10 production in lymphoid tissues, provide a clear rationale for testing the biological role of B cell-derived IL-10 in infectious and inflammatory disease, and underscore the utility of cell type-specific knockouts for mechanistic limning of immune counter-regulation.

Citing Articles

The remodeling of B-cell subsets was correlated with the clearance of hepatitis B antigen during pegylated IFN α-2a therapy in CHB patients.

Tan L, Mo Z, Gan W, Gao Z, Zhu J, Wu Z Ann Med. 2025; 57(1):2463569.

PMID: 39957563 PMC: 11834791. DOI: 10.1080/07853890.2025.2463569.


Neutrophil extracellular traps promote pre-metastatic niche formation in the omentum by expanding innate-like B cells that express IL-10.

Lee W, Ko S, Akasaka H, Weigert M, Lengyel E, Naora H Cancer Cell. 2025; 43(1):69-85.e11.

PMID: 39753138 PMC: 11732717. DOI: 10.1016/j.ccell.2024.12.004.


Dysfunction and regulatory interplay of T and B cells in chronic hepatitis B: immunotherapy and emerging antiviral strategies.

Yu F, Zhu Y, Li S, Hao L, Li N, Ye F Front Cell Infect Microbiol. 2024; 14:1488527.

PMID: 39717542 PMC: 11663751. DOI: 10.3389/fcimb.2024.1488527.


Turncoat antibodies unmasked in a model of autoimmune demyelination: from biology to therapy.

Taghipour-Mirakmahaleh R, Morin F, Zhang Y, Bourhoven L, Beland L, Zhou Q bioRxiv. 2024; .

PMID: 39677612 PMC: 11642901. DOI: 10.1101/2024.12.03.623846.


The current understanding of the phenotypic and functional properties of human regulatory B cells (Bregs).

Ahsan N, Lourenco S, Psyllou D, Long A, Shankar S, Bashford-Rogers R Oxf Open Immunol. 2024; 5(1):iqae012.

PMID: 39346706 PMC: 11427547. DOI: 10.1093/oxfimm/iqae012.


References
1.
Dragin N, Shi Z, Madan R, Karp C, Sartor M, Chen C . Phenotype of the Cyp1a1/1a2/1b1-/- triple-knockout mouse. Mol Pharmacol. 2008; 73(6):1844-56. PMC: 2735564. DOI: 10.1124/mol.108.045658. View

2.
Standiford T, Strieter R, Lukacs N, Kunkel S . Neutralization of IL-10 increases lethality in endotoxemia. Cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor. J Immunol. 1995; 155(4):2222-9. View

3.
Ishida H, Hastings R, Thompson-Snipes L, Howard M . Modified immunological status of anti-IL-10 treated mice. Cell Immunol. 1993; 148(2):371-84. DOI: 10.1006/cimm.1993.1119. View

4.
Kayaba H, Dombrowicz D, Woerly G, Papin J, Loiseau S, Capron M . Human eosinophils and human high affinity IgE receptor transgenic mouse eosinophils express low levels of high affinity IgE receptor, but release IL-10 upon receptor activation. J Immunol. 2001; 167(2):995-1003. DOI: 10.4049/jimmunol.167.2.995. View

5.
Rousset F, Garcia E, Defrance T, Peronne C, Vezzio N, Hsu D . Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci U S A. 1992; 89(5):1890-3. PMC: 48559. DOI: 10.1073/pnas.89.5.1890. View